Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

May 24, 2000

Mintezol(r) Chewable Tablets Recalled

West Point, PA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Merck and Company is conducting a recall of Mintezol(r) Chewable (Thiabendazole) Tablets, USP, 500 mg, in unit dose packages of 36 tablets, because an unapproved binding agent was used in formulation.

The recalled Mintezol is a prescription used for the treatment of parasitic infections and bears one of the following Lot Numbers and EXP Dates:
J800 EXP Jan 04, J8001 EXP Jan 04, J8002 EXP Jan 04, J8003 EXP Jan 04, J8004 EXP Jan 04, J8005 EXP Jan 04, J8011 EXP Feb 04, J8012 EXP Feb 04, J8013 EXP Mar 04, J8014 EXP Feb 04, J8016 EXP Feb 04, J8017 EXP Feb 04.

FDA stated in its report that 24,163 units were distributed nationwide and internationally.

This ongoing Class II recall was initiated by the company, by letter dated March 20, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-352-0

Notice of this product warning was sent via email to SafeMail subscribers May 24, 2000.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.